4//SEC Filing
Derovan Netanel 4
Accession 0001213900-22-001617
CIK 0001176309other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:40 PM ET
Size
7.3 KB
Accession
0001213900-22-001617
Insider Transaction Report
Form 4
Derovan Netanel
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-09+30,000→ 30,000 totalExercise: $12.03Exp: 2032-01-03→ Common Stock (30,000 underlying) - Award
Common Stock
2022-01-09+18,000→ 18,000 total
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]The Stock Option will vest in 4 installments as follows: 7,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001901330
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 8:40 PM ET
- Size
- 7.3 KB